Treatment of brain metastases in patients with HER2+ breast cancer.
about
Long-term survivor characteristics in HER2-positive metastatic breast cancer from registHER.Prediction of outcomes for patients with brain parenchymal metastases from breast cancer (BC): a new BC-specific prognostic model and a nomogram.Monoclonal antibodies in neuro-oncology: Getting past the blood-brain barrier.Pathogenesis of Breast Cancer Metastasis to Brain: a Comprehensive Approach to the Signaling Network.Molecular determinants of lung cancer metastasis to the central nervous system.
P2860
Treatment of brain metastases in patients with HER2+ breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Treatment of brain metastases in patients with HER2+ breast cancer.
@en
Treatment of brain metastases in patients with HER2+ breast cancer.
@nl
type
label
Treatment of brain metastases in patients with HER2+ breast cancer.
@en
Treatment of brain metastases in patients with HER2+ breast cancer.
@nl
prefLabel
Treatment of brain metastases in patients with HER2+ breast cancer.
@en
Treatment of brain metastases in patients with HER2+ breast cancer.
@nl
P2860
P1433
P1476
Treatment of brain metastases in patients with HER2+ breast cancer.
@en
P2093
J M Bravo Marques
P2860
P2888
P304
P356
10.1007/S12325-009-0047-0
P407
P478
26 Suppl 1
P577
2009-07-24T00:00:00Z